SCHEMBL7979982

SCHEMBL7979982

COc1cc2nc(Nc3c(F)cccc3F)c3cncn3c2cc1OC

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.78
LYN P07948 1/20 0.51
BTK Q06187 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987285 0.93 LCK (0.80) LCK
SCHEMBL7980258 0.92 LCK (0.69) LCKLYNBTK
SCHEMBL7988026 0.90 LCK (0.69) LCKLYNBTK
SCHEMBL7983098 0.87 LCK (1.00) LCK
SCHEMBL7984253 0.86 LCK (0.78) LCK
SCHEMBL7980799 0.86 LCK (0.88) LCK
SCHEMBL7980266 0.83 LCK (0.66) LCKLYNBTK
SCHEMBL7982912 0.83 LCK (0.76) LCK
SCHEMBL7980346 0.83 LCK (0.62) LCKLYNBTK
SCHEMBL7983636 0.83 LCK (0.62) LCKLYNBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed